{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:43:42Z","timestamp":1786121022029,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Joint Construction Program","award":["LHGH20250856"],"award-info":[{"award-number":["LHGH20250856"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05340-2","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:14:27Z","timestamp":1780517667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrated machine learning and mendelian randomization approach identifies SERPING1 as a prognostic biomarker associated with CD8\u2009+\u2009T-cell infiltration in DLBCL"],"prefix":"10.1007","volume":"17","author":[{"given":"Jinhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"5340_CR1","first-page":"3602","volume":"15","author":"M Horvat","year":"2018","unstructured":"Horvat M, et al. Diffuse large B-cell lymphoma: 10 years\u2019 real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. Oncol Lett. 2018;15(3):3602\u20139.","journal-title":"Oncol Lett"},{"issue":"12","key":"5340_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-020-00389-w","volume":"10","author":"TJ Bakhshi","year":"2020","unstructured":"Bakhshi TJ, Georgel PT. Genetic and epigenetic determinants of diffuse large B-cell lymphoma. Blood Cancer J. 2020;10(12):123.","journal-title":"Blood Cancer J"},{"key":"5340_CR3","first-page":"351","volume":"8","author":"J Zhang","year":"2018","unstructured":"Zhang J, Medeiros LJ, Young KH. Cancer Immunotherapy Diffuse Large B-Cell Lymphoma Front Oncol. 2018;8:351.","journal-title":"Cancer Immunotherapy Diffuse Large B-Cell Lymphoma Front Oncol"},{"issue":"4","key":"5340_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"issue":"3","key":"5340_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","volume":"32","author":"K Karube","year":"2018","unstructured":"Karube K, et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia. 2018;32(3):675\u201384.","journal-title":"Leukemia"},{"key":"5340_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-0716-2756-3_5","volume":"2584","author":"V Hahaut","year":"2023","unstructured":"Hahaut V, Picelli S. Full-Length Single-Cell RNA-Sequencing with FLASH-seq. Methods Mol Biol. 2023;2584:123\u201364.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"5340_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12894-025-01914-4","volume":"25","author":"H Dai","year":"2025","unstructured":"Dai H, et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 2025;25(1):229.","journal-title":"BMC Urol"},{"issue":"1","key":"5340_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56.","journal-title":"Biol Direct"},{"issue":"1","key":"5340_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","volume":"26","author":"H Dai","year":"2026","unstructured":"Dai H, et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int. 2026;26(1):15.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"5340_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2174\/1573409919666230525154120","volume":"20","author":"Q Zhong","year":"2024","unstructured":"Zhong Q, et al. Molecular Docking and Molecular Dynamics Simulation of New Potential JAK3 Inhibitors. Curr Comput Aided Drug Des. 2024;20(6):764\u201372.","journal-title":"Curr Comput Aided Drug Des"},{"key":"5340_CR11","first-page":"p164","volume":"2023","author":"H Huang","year":"2023","unstructured":"Huang H, et al. Feature Selection for Unsupervised Machine Learning. IEEE Int Conf Smart Cloud. 2023;2023:p164\u2013169.","journal-title":"IEEE Int Conf Smart Cloud"},{"issue":"1","key":"5340_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell Div. 2025;20(1):27.","journal-title":"Cell Div"},{"issue":"1","key":"5340_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai H, et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162(1):42.","journal-title":"Hereditas"},{"issue":"1","key":"5340_CR14","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1002\/cpmb.57","volume":"122","author":"TK Olsen","year":"2018","unstructured":"Olsen TK, Baryawno N. Introduction to Single-Cell RNA Sequencing. Curr Protoc Mol Biol. 2018;122(1):e57.","journal-title":"Curr Protoc Mol Biol"},{"issue":"1","key":"5340_CR15","doi-asserted-by":"publisher","first-page":"105562","DOI":"10.1016\/j.jbc.2023.105562","volume":"300","author":"T Yu","year":"2024","unstructured":"Yu T, et al. Single-cell RNA-seq and single-cell bisulfite-sequencing reveal insights into yak preimplantation embryogenesis. J Biol Chem. 2024;300(1):105562.","journal-title":"J Biol Chem"},{"issue":"1","key":"5340_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365519609088581","volume":"56","author":"EM Wallace","year":"1996","unstructured":"Wallace EM, Feighery C, Jackson J. A solid-phase antibody capture assay for the measurement of C1-inhibitor consumption in vivo. Scand J Clin Lab Invest. 1996;56(1):1\u20139.","journal-title":"Scand J Clin Lab Invest"},{"key":"5340_CR17","doi-asserted-by":"publisher","first-page":"1624512","DOI":"10.3389\/fgene.2025.1624512","volume":"16","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, et al. The roles of serine protease inhibitors in dermatoses. Front Genet. 2025;16:1624512.","journal-title":"Front Genet"},{"issue":"49","key":"5340_CR18","doi-asserted-by":"publisher","first-page":"e2401968121","DOI":"10.1073\/pnas.2401968121","volume":"121","author":"MJ Topper","year":"2024","unstructured":"Topper MJ, et al. Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes. Proc Natl Acad Sci U S A. 2024;121(49):e2401968121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5340_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-0031-1276585","volume":"37","author":"S Zeerleder","year":"2011","unstructured":"Zeerleder S. C1-inhibitor: more than a serine protease inhibitor. Semin Thromb Hemost. 2011;37(4):362\u201374.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"5340_CR20","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-024-46220-z","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, et al. Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma. Nat Commun. 2024;15(1):2113.","journal-title":"Nat Commun"},{"issue":"7","key":"5340_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","volume":"7","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, et al. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth. Cancer Immunol Res. 2019;7(7):1091\u2013105.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"5340_CR22","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1038\/s41467-024-49495-4","volume":"15","author":"ZX Yan","year":"2024","unstructured":"Yan ZX, et al. Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nat Commun. 2024;15(1):5183.","journal-title":"Nat Commun"},{"issue":"1","key":"5340_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1538\/expanim.19-0076","volume":"69","author":"M Hamada","year":"2020","unstructured":"Hamada M, et al. Role of MafB in macrophages. Exp Anim. 2020;69(1):1\u201310.","journal-title":"Exp Anim"},{"issue":"18","key":"5340_CR24","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.yexcr.2012.07.011","volume":"318","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Chen Q, Ross AC. Retinoic acid and tumor necrosis factor-\u03b1 induced monocytic cell gene expression is regulated in part by induction of transcription factor MafB. Exp Cell Res. 2012;318(18):2407\u201316.","journal-title":"Exp Cell Res"},{"issue":"1","key":"5340_CR25","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1038\/s41598-017-07381-8","volume":"7","author":"H Kim","year":"2017","unstructured":"Kim H. The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages. Sci Rep. 2017;7(1):7591.","journal-title":"Sci Rep"},{"key":"5340_CR26","doi-asserted-by":"publisher","first-page":"1389194","DOI":"10.3389\/fimmu.2024.1389194","volume":"15","author":"L Ouologuem","year":"2024","unstructured":"Ouologuem L, Bartel K. Endolysosomal transient receptor potential mucolipins and two-pore channels: implications for cancer immunity. Front Immunol. 2024;15:1389194.","journal-title":"Front Immunol"},{"key":"5340_CR27","doi-asserted-by":"publisher","first-page":"807696","DOI":"10.3389\/fimmu.2022.807696","volume":"13","author":"H Aoki","year":"2022","unstructured":"Aoki H, et al. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis. Front Immunol. 2022;13:807696.","journal-title":"Front Immunol"},{"issue":"4","key":"5340_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.drudis.2021.01.002","volume":"26","author":"S Kumar","year":"2021","unstructured":"Kumar S, et al. Tumor-infiltrating CD8(+) T cell antitumor efficacy and exhaustion: molecular insights. Drug Discov Today. 2021;26(4):951\u201367.","journal-title":"Drug Discov Today"},{"key":"5340_CR29","doi-asserted-by":"publisher","first-page":"15659","DOI":"10.1038\/srep15659","volume":"5","author":"CW Kang","year":"2015","unstructured":"Kang CW, et al. Apoptosis of tumor infiltrating effector TIM-3\u2009+\u2009CD8+ T cells in colon cancer. Sci Rep. 2015;5:15659.","journal-title":"Sci Rep"},{"issue":"1","key":"5340_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, et al. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment. Cell Metab. 2019;30(1):143\u2013e1565.","journal-title":"Cell Metab"},{"issue":"7","key":"5340_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41556-022-00942-8","volume":"24","author":"L Zhu","year":"2022","unstructured":"Zhu L, et al. Dapl1 controls NFATc2 activation to regulate CD8(+) T cell exhaustion and responses in chronic infection and cancer. Nat Cell Biol. 2022;24(7):1165\u201376.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"5340_CR32","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","volume":"72","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res. 2012;72(10):2473\u201380.","journal-title":"Cancer Res"},{"issue":"3","key":"5340_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3324\/haematol.2019.243626","volume":"106","author":"M Autio","year":"2021","unstructured":"Autio M, et al. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma. Haematologica. 2021;106(3):718\u201329.","journal-title":"Haematologica"},{"key":"5340_CR34","doi-asserted-by":"publisher","first-page":"1048567","DOI":"10.3389\/fimmu.2023.1048567","volume":"14","author":"L Serna","year":"2023","unstructured":"Serna L, et al. Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature. Front Immunol. 2023;14:1048567.","journal-title":"Front Immunol"},{"key":"5340_CR35","doi-asserted-by":"publisher","first-page":"1265255","DOI":"10.3389\/fimmu.2023.1265255","volume":"14","author":"J Ma","year":"2023","unstructured":"Ma J, et al. Blockade of PD-1 and LAG-3 expression on CD8\u2009+\u2009T cells promotes the tumoricidal effects of CD8\u2009+\u2009T cells. Front Immunol. 2023;14:1265255.","journal-title":"Front Immunol"},{"issue":"2","key":"5340_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5045\/br.2022.2021145","volume":"57","author":"AM Greenbaum","year":"2022","unstructured":"Greenbaum AM, et al. Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8(+) T-cells despite immune checkpoint signaling. Blood Res. 2022;57(2):117\u201328.","journal-title":"Blood Res"},{"key":"5340_CR37","first-page":"p4972043","volume":"2021","author":"T Zhang","year":"2021","unstructured":"Zhang T, et al. Corrigendum to Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma. J Immunol Res. 2021;2021:p4972043.","journal-title":"J Immunol Res"},{"key":"5340_CR38","doi-asserted-by":"crossref","unstructured":"Zhang T et al. Genetic characteristics involving the PD-1\/PD-L1\/L2 and CD73\/A2aR axes and the immunosuppressive microenvironment in DLBCL. J Immunother Cancer, 2022. 10(4).","DOI":"10.1136\/jitc-2021-004114"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05340-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:32:35Z","timestamp":1786069955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05340-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5340"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05340-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complies with the data access policies of the databases used and mainly relies on public datasets; Thus, no further ethical review is required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1134"}}